Literature DB >> 168248

The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.

L M Hutt.   

Abstract

The onset, duration and magnitude of antibody responses to a poxvirus infection were examined. Mice were inoculated intravenously with the WR strain of vaccinia virus and developed pocks on their tails. The number of pocks was related to the size of the inoculum. Virus was detectable in the spleen and infected mice were subsequently immune to intravenous and intra-nasal challenge. Sera of infected animals neutralized both cell-free and cell-associated virus. Antibody against cell-free virus appeared first; maximum titres were reached sooner but were lower than those of antibody neutralizing cell-associated virus. Titres remained high for at least 100 days after infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168248      PMCID: PMC2130604          DOI: 10.1017/s0022172400046829

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  25 in total

1.  The nature of the immune state produced by inactivated vaccinia virus in rabbits.

Authors:  E A Boulter; H T Zwartouw; D H Titmuss; H B Maber
Journal:  Am J Epidemiol       Date:  1971-12       Impact factor: 4.897

2.  Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.

Authors:  Y Ichihashi; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

3.  Protection against poxviruses.

Authors:  E A Boulter
Journal:  Proc R Soc Med       Date:  1969-03-03

4.  Mechanism of recovery from systemic infection with vaccinia virus. II. Effects of x-irradiation and neonatal thymectomy.

Authors:  M Worthington
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

5.  Protection of mice against vaccinia virus by bacterial infection and sustained stimulation with specific bacterial antigens.

Authors:  E G Allen; S Mudd
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

6.  Iodine-125-labeled antibody to viral antigens: binding to the surface of virus-infected cells.

Authors:  K Hayashi; J Rosenthal; A L Notkins
Journal:  Science       Date:  1972-05-05       Impact factor: 47.728

7.  The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.

Authors:  L M Hutt
Journal:  J Hyg (Lond)       Date:  1975-06

8.  Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

9.  Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

10.  Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  5 in total

1.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.

Authors:  J A Byrne; M Soloski; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  The immune response to vaccinia virus infection in mice: analysis of the role of antibody.

Authors:  F J Novembre; K Raska; J A Holowczak
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.

Authors:  L M Hutt
Journal:  J Hyg (Lond)       Date:  1975-06

5.  Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer.

Authors:  J R Tysome; A Briat; G Alusi; F Cao; D Gao; J Yu; P Wang; S Yang; Z Dong; S Wang; L Deng; J Francis; T Timiryasova; I Fodor; N R Lemoine; Y Wang
Journal:  Gene Ther       Date:  2009-07-09       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.